Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Germani

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|October 30, 2009
Re: Antitumor efficacy testing in rodentsItalo Poggesi, Giuseppe de Nicolao, Massimiliano Germani, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2013
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combinationNadia Terranova, Massimiliano Germani, Francesca Del Bene, et al.
Journal of Pharmaceutical Sciences|November 4, 2023
A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine DevelopmentRajat Desikan, Massimiliano Germani, Piet H van der Graaf, et al.
Brain : a Journal of Neurology|November 28, 2025
Brain connectivity as a new target for Alzheimer's disease therapy?Lorenzo Pini, Gilles Allali, Bruno P Imbimbo, et al.
Computer Methods and Programs in Biomedicine|November 28, 2012
A4S: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulationMassimiliano Germani, Francesca Del Bene, Maurizio Rocchetti, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2003
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment timeMassimiliano Germani, Paolo Magni, Giuseppe De Nicolao, et al.
IEEE Transactions on Bio-Medical Engineering|January 8, 2009
A minimal model of tumor growth inhibitionPaolo Magni, Massimiliano Germani, Giuseppe De Nicolao, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2023
Population pharmacokinetic-pharmacodynamic analysis of givinostatFrancesco Fiorentini, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2013
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenograftsMaurizio Rocchetti, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2008
A model-based approach to the in vitro evaluation of anticancer activityFrancesca Del Bene, Massimiliano Germani, Giuseppe De Nicolao, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|October 30, 2009
Re: Antitumor efficacy testing in rodentsItalo Poggesi, Giuseppe de Nicolao, Massimiliano Germani, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2013
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combinationNadia Terranova, Massimiliano Germani, Francesca Del Bene, et al.
Journal of Pharmaceutical Sciences|November 4, 2023
A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine DevelopmentRajat Desikan, Massimiliano Germani, Piet H van der Graaf, et al.
Brain : a Journal of Neurology|November 28, 2025
Brain connectivity as a new target for Alzheimer's disease therapy?Lorenzo Pini, Gilles Allali, Bruno P Imbimbo, et al.
Computer Methods and Programs in Biomedicine|November 28, 2012
A4S: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulationMassimiliano Germani, Francesca Del Bene, Maurizio Rocchetti, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2003
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment timeMassimiliano Germani, Paolo Magni, Giuseppe De Nicolao, et al.
IEEE Transactions on Bio-Medical Engineering|January 8, 2009
A minimal model of tumor growth inhibitionPaolo Magni, Massimiliano Germani, Giuseppe De Nicolao, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2023
Population pharmacokinetic-pharmacodynamic analysis of givinostatFrancesco Fiorentini, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2013
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenograftsMaurizio Rocchetti, Massimiliano Germani, Francesca Del Bene, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2008
A model-based approach to the in vitro evaluation of anticancer activityFrancesca Del Bene, Massimiliano Germani, Giuseppe De Nicolao, et al.
Pageof 3